Monness Crespi upgraded MongoDB (MDB) to Buy from Neutral with a $295 price target The company last night reported Q1 upside, issued a “healthy” Q2 outlook, raised its fiscal 2026 guidance, and announced a new $800M stock repurchase program, the analyst tells investors in a research note. The firm says that after sinking 43% in 2024, the stock has declined another 14% this year, creating an attractive valuation at current levels. Atlas exited its “protracted growth slump” in Q1, and MongoDB will emerge an important beneficiary of the long-term generative artificial intelligence trend, contends Monness. As such, the firm believes the shares are “worthy of a rally.”
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MDB:
- MongoDB upgraded to Buy from Neutral at Monness Crespi
- MongoDB’s Strong Performance and Growth Prospects Drive Buy Rating and Increased Price Target
- MongoDB price target raised to $260 from $235 at Guggenheim
- MongoDB price target raised to $275 from $200 at Piper Sandler
- MongoDB price target raised to $275 from $215 at BofA
